Interleukin-6 dependent survival of multiple myeloma cells involves the Stat3-mediated induction of microRNA-21 through a highly conserved enhancer - PubMed (original) (raw)
. 2007 Aug 15;110(4):1330-3.
doi: 10.1182/blood-2007-03-081133. Epub 2007 May 11.
Katja Brocke-Heidrich, Gabriele Pfeifer, Claudia Stocsits, Jörg Hackermüller, Antje K Kretzschmar, Renate Burger, Martin Gramatzki, Conny Blumert, Kay Bauer, Helena Cvijic, A Kerstin Ullmann, Peter F Stadler, Friedemann Horn
Affiliations
- PMID: 17496199
- DOI: 10.1182/blood-2007-03-081133
Free article
Interleukin-6 dependent survival of multiple myeloma cells involves the Stat3-mediated induction of microRNA-21 through a highly conserved enhancer
Dennis Löffler et al. Blood. 2007.
Free article
Abstract
Signal transducer and activator of transcription 3 (Stat3) is implicated in the pathogenesis of many malignancies and essential for IL-6-dependent survival and growth of multiple myeloma cells. Here, we demonstrate that the gene encoding oncogenic microRNA-21 (miR-21) is controlled by an upstream enhancer containing 2 Stat3 binding sites strictly conserved since the first observed evolutionary appearance of miR-21 and Stat3. MiR-21 induction by IL-6 was strictly Stat3 dependent. Ectopically raising miR-21 expression in myeloma cells in the absence of IL-6 significantly reduced their apoptosis levels. These data provide strong evidence that miR-21 induction contributes to the oncogenic potential of Stat3.
Similar articles
- BCL3 is induced by IL-6 via Stat3 binding to intronic enhancer HS4 and represses its own transcription.
Brocke-Heidrich K, Ge B, Cvijic H, Pfeifer G, Löffler D, Henze C, McKeithan TW, Horn F. Brocke-Heidrich K, et al. Oncogene. 2006 Nov 23;25(55):7297-304. doi: 10.1038/sj.onc.1209711. Epub 2006 May 29. Oncogene. 2006. PMID: 16732314 - Interleukin-6-dependent gene expression profiles in multiple myeloma INA-6 cells reveal a Bcl-2 family-independent survival pathway closely associated with Stat3 activation.
Brocke-Heidrich K, Kretzschmar AK, Pfeifer G, Henze C, Löffler D, Koczan D, Thiesen HJ, Burger R, Gramatzki M, Horn F. Brocke-Heidrich K, et al. Blood. 2004 Jan 1;103(1):242-51. doi: 10.1182/blood-2003-04-1048. Epub 2003 Sep 11. Blood. 2004. PMID: 12969979 - Stat1 activation attenuates IL-6 induced Stat3 activity but does not alter apoptosis sensitivity in multiple myeloma.
Dimberg LY, Dimberg A, Ivarsson K, Fryknäs M, Rickardson L, Tobin G, Ekman S, Larsson R, Gullberg U, Nilsson K, Öberg F, Wiklund HJ. Dimberg LY, et al. BMC Cancer. 2012 Jul 28;12:318. doi: 10.1186/1471-2407-12-318. BMC Cancer. 2012. PMID: 22838736 Free PMC article. - Cyclophilins contribute to Stat3 signaling and survival of multiple myeloma cells.
Bauer K, Kretzschmar AK, Cvijic H, Blumert C, Löffler D, Brocke-Heidrich K, Schiene-Fischer C, Fischer G, Sinz A, Clevenger CV, Horn F. Bauer K, et al. Oncogene. 2009 Aug 6;28(31):2784-95. doi: 10.1038/onc.2009.142. Epub 2009 Jun 8. Oncogene. 2009. PMID: 19503092 - MicroRNA-21 and multiple myeloma: small molecule and big function.
Ma J, Liu S, Wang Y. Ma J, et al. Med Oncol. 2014 Aug;31(8):94. doi: 10.1007/s12032-014-0094-5. Epub 2014 Jul 1. Med Oncol. 2014. PMID: 24981236 Review.
Cited by
- MiRNAs in primary cutaneous lymphomas.
Yu X, Li Z, Liu J. Yu X, et al. Cell Prolif. 2015 Jun;48(3):271-7. doi: 10.1111/cpr.12179. Epub 2015 Mar 3. Cell Prolif. 2015. PMID: 25736784 Free PMC article. Review. - Investigational agent MLN9708/2238 targets tumor-suppressor miR33b in MM cells.
Tian Z, Zhao JJ, Tai YT, Amin SB, Hu Y, Berger AJ, Richardson P, Chauhan D, Anderson KC. Tian Z, et al. Blood. 2012 Nov 8;120(19):3958-67. doi: 10.1182/blood-2012-01-401794. Epub 2012 Sep 14. Blood. 2012. PMID: 22983447 Free PMC article. - miRNA-regulated gene expression differs in celiac disease patients according to the age of presentation.
Buoli Comani G, Panceri R, Dinelli M, Biondi A, Mancuso C, Meneveri R, Barisani D. Buoli Comani G, et al. Genes Nutr. 2015 Sep;10(5):482. doi: 10.1007/s12263-015-0482-2. Epub 2015 Aug 2. Genes Nutr. 2015. PMID: 26233308 Free PMC article. - Sulindac inhibits tumor cell invasion by suppressing NF-κB-mediated transcription of microRNAs.
Li X, Gao L, Cui Q, Gary BD, Dyess DL, Taylor W, Shevde LA, Samant RS, Dean-Colomb W, Piazza GA, Xi Y. Li X, et al. Oncogene. 2012 Nov 29;31(48):4979-86. doi: 10.1038/onc.2011.655. Epub 2012 Jan 30. Oncogene. 2012. PMID: 22286762 Free PMC article. - MicroRNAs: New Players in Multiple Myeloma.
Pichiorri F, De Luca L, Aqeilan RI. Pichiorri F, et al. Front Genet. 2011 May 24;2:22. doi: 10.3389/fgene.2011.00022. eCollection 2011. Front Genet. 2011. PMID: 22303318 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous